Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,545,227
-$2,148,922 QoQ
Shares Held
53,354
-47.5% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#171
of 477 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Jun 30, 2024CallValue
$65,016
CallShares
1,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. CYTK ranks #25 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in CYTK
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,545,227 | 53,354 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,694,149 | 101,565 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $7,052,460 | 175,478 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $850,571 | 15,699 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $65,016 | 1,200 | Call | Sole | 2024-08-14 | |
| 2024-03-31 | $525,825 | 7,500 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $2,777,337 | 39,614 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $330,954 | 3,964 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $317,262 | 3,800 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $408,934 | 13,881 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,005,250 | 30,817 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $965,402 | 27,434 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,605,371 | 56,861 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $3,118,290 | 79,366 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $301,842 | 8,200 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,635,486 | 101,700 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,841,901 | 79,516 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $401,737 | 20,300 | Shares | Sole | 2021-11-16 | |
| 2020-03-31 | $156,370 | 13,263 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||